소프트젤 캡슐 세계 시장은 2025-2032년의 예측 기간 동안 5.45%의 연평균 복합 성장률(CAGR)을 나타내고, 2024년 23억 4,000만 달러에서 2032년 35억 8,000만 달러에 달할 것으로 예측됩니다. 시장 발전의 배경에는 제약 산업의 급속한 확장, 연구 개발 활동에 대한 투자 증가, 신제품 및 신기술 도입에 대한 관심 증가가 있습니다. 소프트젤 캡슐은 일반적으로 삼키기 쉽고, 생체이용률이 높으며, 불쾌한 냄새와 맛을 숨길 수 있는 기능으로 인해 선호되고 있습니다. 오메가3 지방산, 비타민, 한약재 등 식품 보충제에 대한 고객 수요 증가도 시장 성장의 주요 촉진요인입니다.
또한, 고령화 사회의 건강 지향성 증가와 예방의학에 대한 관심 증가도 시장 확대를 뒷받침하고 있습니다. 하이드록시프로파일메틸셀룰로오스 및 타피오카 전분 유래 캡슐을 포함한 식물성 대체품 등 기술 혁신에 대한 투자는 채식주의자 대체품에 대한 수요 증가에 대응하기 위해 이루어지고 있습니다. 한편, 제조 공정의 기술 발전은 제품의 다양성을 높이고 생산 효율을 향상시키는 데 도움이 되고 있습니다.
Global softgel capsules market is projected to witness a CAGR of 5.45% during the forecast period 2025-2032, growing from USD 2.34 billion in 2024 to USD 3.58 billion in 2032. The growth of the market can be attributed to the rapid expansion of the pharmaceutical industry, increasing investments in research and development activities, and a growing focus on the introduction of novel products and technologies. Softgel capsules are usually preferred due to their ease of swallowing, improved bioavailability, and the ability to mask unpleasant odors and flavors. Increasing customer demand for food supplements such as omega-3 fatty acids, vitamins, and herbal medication is also a major market driver.
Additionally, the market's expansion is also supported by the increasing health consciousness among the aging population and the increasing emphasis on preventive healthcare. Investments in innovations such as plant-based alternatives, including capsules derived from hydroxypropyl methylcellulose and tapioca starch, are being made to address the growing requirement for vegetarian alternatives. Meanwhile, technological advancements in manufacturing processes are aiding in increasing product diversity and improving production efficiency.
Novel Launches Bolster Market Growth
Key manufacturers and leading players in the market are increasingly focusing on launching new formulations to cater to the evolving industry demands and requirements of consumers. Companies across the globe are increasingly focusing on developing vegan and plant-based softgel capsules to appeal to health and environmentally conscious consumers seeking alternatives to traditional capsules. For instance, in May 2024, Roquette Group launched LYCAGEL Flex hydroxypropyl pea starch premix for pharmaceutical and nutraceutical softgel capsules. The premix aids manufacturers in customizing formulations by selecting optimal plasticizer combinations, catering to the diverse requirements of both producers and end-users. Additionally, LYCAGEL Flex addresses the various challenges associated with gelatin-based capsules, including interactions with specific fill types, molecular crosslinking, and sensitivity to heat and moisture.
Moreover, the launch of new products with advanced encapsulation technologies, including the development of delayed-release and enteric-coated softgels are improving the bioavailability and therapeutic efficacy of the medications. These innovations allow for more effective delivery of active ingredients, particularly for sensitive compounds that require protection from gastric acid, increasing physician confidence in the product and bolstering demand.
Rising Collaborations Support Market Expansion
The increase in collaborations between leading pharmaceutical companies to support research and development activities is one of the major drivers of the market, as such efforts allow them to innovate novel therapeutic solutions and leverage one another's strengths, including market reach and technical expertise.
For instance, in February 2025, Jupiter Neurosciences Inc. partnered with Catalent Pharma Solutions LLC to produce JOTROL softgel capsules to support the former's upcoming Phase 2a clinical trial in Parkinson's disease. The trial is going to evaluate the pharmacokinetics/pharmacodynamics, safety, and tolerability of JOTROL over three months. Such collaborations are expected to bolster the availability of novel treatment options for neurodegenerative diseases, propelling the requirement for softgel capsules and providing lucrative growth opportunities for the market.
Such collaborations are also allowing the development of novel softgel products that meet the previously unmet requirements of the patient population. By pooling resources pharmaceutical companies are also able to improve the accessibility and affordability of the end product, allowing them to capture a broader share of the market.
Nutraceutical Companies Account for Significant Share of the Market
The increasing adoption of preventive healthcare approaches is resulting in higher consumption of herbal supplements, omega-3 fatty acids, vitamins, and minerals, which are often formulated in softgel form. These capsules are preferred for nutraceutical applications due to the ease of swallowing offered by these capsules, along with high bioavailability. They also improve the stability of fat-soluble and oil-based nutrients, further increasing their preference for delivering herbal and nutritional ingredients as compared to other tablets and powders.
Additionally, the growing popularity of health and wellness trends, including cognitive functions, gut health, and immunity-boosting supplements, has further increased the demand for softgel capsules. To meet this growing demand, leading nutraceutical companies are increasingly focusing on mergers and acquisitions, new product launches, and research and development activities.
Moreover, the rising investments in the nutraceutical CDMOs are also supporting the segment's growth. For instance, in March 2025, Tirupati Medicare Ltd. received an investment of approximately USD 122 million, allowing them to expand their product portfolio and manufacturing capabilities. Additionally, the investment is also expected to support Tirupati in implementing various inorganic growth strategies and help drive sales.
North America Region Holds Major Market Share
The dominance of the region can be attributed to high consumer awareness of health and wellness products, driven by the growing demand for dietary supplements and nutraceuticals. The United States dominates the North American market, supported by an aging population and increasing demand for supplements targeting chronic disease prevention. According to the estimates of the Population Reference Bureau, the number of individuals aged 65 and above is estimated to increase to 82 million by 2050 from 58 million in 2022. The presence of major pharmaceutical and nutraceutical manufacturers in North America contributes significantly to market growth. Companies in the region invest heavily in research and development to expand their product portfolios, including innovations in non-gelatin and plant-based capsules to cater to diverse consumer preferences. Additionally, advanced production technologies and robust distribution networks, including pharmacies, supermarkets, and online platforms, ensure widespread accessibility of softgel capsules. Moreover, the region benefits from a strong regulatory framework that ensures high-quality production standards, enhancing consumer trust. These factors collectively position North America as a dominant player in the global softgel capsules market.
Future Market Scenario (2025-2032F)
As per the global softgel capsules market analysis, the market's demand is expected to increase significantly in the coming years due to the growing requirement for dietary supplements as health consciousness among consumers rises. Some of the innovations and advancements in the market would include advancements in encapsulation technologies, including nano-emulsion formulations and sustained release. As the preference for sustainability, convenience, and efficacy increases, the market is expected to encounter lucrative growth opportunities.
Meanwhile, the key players in the industry are expected to focus on the expansion of manufacturing facilities, new product launches, and strategic acquisitions to stay competitive in this industry and hold their position.
Key Players Landscape and Outlook
The leading players across the globe are actively investing in launching new products with enhanced features, providing lucrative growth opportunities. For instance, in March 2024, LEE HEALTH DOMAIN (I) PVT. LTD., an Indian nutraceutical company, launched Lyphosterol, a natural polypill supplement for heart care. The soft gel capsule contains bioactive compounds from aged garlic extract, gamma oryzanol, phytosterol, lycopene, nano curcumin, fenugreek, and piperine. These compounds effectively balance cholesterol and triglyceride levels, remove soft plaque in arteries, stabilize irregular heartbeats, protect against free radicals, and reduce heart disease risk.
Additionally, the companies are also engaging in mergers and acquisitions to expand their product portfolios, improve their manufacturing capabilities, and enhance their reach. For instance, in March 2023, Darling Ingredients Inc. completed its acquisition of Gelnex, Inc., a Brazilian gelatin and collagen producer. The acquisition includes five facilities in South America and one in the United States, providing Darling Ingredients with the capacity to produce 46,000 metric tons of gelatin and collagen every year.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.